Form 4: Axsome Therapeutics CFO Nick Pizzie Reports Stock Option and Unit Awards

Nick Pizzie, CFO of Axsome Therapeutics, reports the acquisition of stock options, restricted stock units (RSUs), and performance stock units (PSUs).

Summary

• Nick Pizzie, the Chief Financial Officer of Axsome Therapeutics, filed a Form 4 detailing changes in beneficial ownership.
• The report indicates the acquisition of 9,516 employee stock options with an exercise price of $137.75, vesting quarterly over four years and fully vested by February 21, 2029.
• Pizzie also acquired 9,423 restricted stock units (RSUs), which vest over four years, with 25% vesting on the first anniversary of the grant date and the remainder in three equal annual installments, fully vested by February 21, 2029.
• Vested RSU shares will be delivered upon a Change in Control, separation of service, or seven years from the grant date.
• Additionally, 9,423 performance stock units (PSUs) were acquired, vesting upon achievement of certain financial, regulatory, and developmental performance milestones.
• All transactions occurred on or around February 21-24, 2025.
• Following these transactions, Pizzie directly owns 9,516 stock options, 9,423 RSUs, and 9,423 PSUs.

Sentiment

Score: 6

Explanation: The document is a routine regulatory filing, indicating standard compensation practices. It doesn't inherently convey positive or negative sentiment, but the granting of equity can be seen as a positive sign of aligning management interests with shareholders.

Positives

• The grant of stock options, RSUs, and PSUs aligns the CFO's interests with those of the shareholders.
• The vesting schedules for the options and units incentivize long-term performance and retention.

Future Outlook

The vesting of the RSUs is contingent upon a Change in Control, separation of service, or seven years from the grant date, while the PSUs vest upon achievement of certain performance milestones, indicating a focus on future performance and potential corporate events.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign, aligning management's interests with the company's long-term success.
• Employees, particularly the CFO, are incentivized to contribute to the company's performance to achieve the vesting conditions of the PSUs.

Key Dates